Clinical Trial Update: A Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002 [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating AGS-1C4D4 in pancreatic cancer patients previously treated in protocol 2008002 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer
• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• AGS-1C4D4

Snippet

Sponsor: Agensys, Inc. | Conditions: Pancreatic Cancer, Carcinoma, Pancreatic Ductal | Phase 2 | Status: COMPLETED